Disease
|
Drug/Important Bio-Agent (IBA)
16 | ibrutinibIBA
11/2023
-
01/2019 |
6 | Agammaglobulinaemia Tyrosine KinaseIBA
11/2023
-
01/2019 |
3 | venetoclaxIBA
11/2023
-
12/2021 |
2 | Chlorambucil (Leukeran)FDA Link
01/2022
-
01/2020 |
2 | AndrogensIBA
05/2013
-
05/2009 |
1 | Phospholipases (Phospholipase)IBA
01/2023 |
1 | obinutuzumabIBA
01/2022 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
05/2017 |
1 | pixantrone (BBR 2778)IBA
08/2016 |
1 | GemcitabineFDA Link
08/2016 |
1 | Rituximab (Mabthera)FDA Link
08/2016 |
1 | Glucose (Dextrose)FDA LinkGeneric
05/2013 |
1 | Insulin-Like PeptidesIBA
05/2013 |
1 | Monoclonal AntibodiesIBA
05/2013 |
1 | cixutumumabIBA
05/2013 |
1 | Insulin-Like Growth Factor Binding Protein 1IBA
05/2013 |
1 | Hormones (Hormone)IBA
05/2009 |
|
Therapy/Procedure
|